العلاج الجذري للهليكوباكتر بيلوري في مصر: العلاج الثلاثي القائم على كلاريثروميسين القياسي مقابل نظام العلاج الرباعي . Helicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy.

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages: 8
Authors:
Journal: Afro-Egypt J Infect Endem Dis 2020;10(2):100-107 Afro-Egypt J Infect Endem Dis 2020;10(2):100-107 Volume: Afro-Egypt J Infect Endem Dis 2020;10(2):100-107
Keywords : العلاج الجذري للهليكوباكتر بيلوري , مصر: العلاج    
Abstract:
Helicobacter Pylori Treatment Eradication in Egypt: Standard Clarithromycin-based Triple versus Quadruple Regimen Therapy Samir A. Afifi1, Neveen G. Elantouny1 , Rehab H. El-sokkary2 , Elsayed S. Abdelbaser3 Internal medicine1, Clinical Pathology2 , Tropical Medicine 3 Abstract Background and study aim: Absence of adequate treatment for Helicobacter pylori (H. pylori) infection leads to prolonged life time colonization which is responsible for complications. Antibiotics resistance is the main cause of eradication failure in H. pylori infection, thus our study aimed to evaluate the efficiency and tolerability of standard triple therapy vs. quadruple regimen therapy in H. pylori eradication in Egypt. Subjects and Methods: Our study enrolled 140 patients (65 males,75 females) who attending to Gastroenterology clinic in Internal medicine & Tropical medicine departments, Zagazig University Hospitals from (June 2018 - June 2019), aged from 20 - 60 years, complained of recurrent non-specific dyspepsia and epigastric pain & proved to be positive for H. pylori stool antigen test. The patients distributed into two groups: group (1), 70 patients given Clarithromycin triple therapy [Clarithromycin 500 mg + Amoxicillin 1gm + Pantoprazole 40 mg, each twice daily]. Group (2), 70 patients given quadruple therapy [Levofloxacin 500 mg once daily + Nitazoxanide 500mg (twice daily)+ Doxycycline 100 mg (twice daily)+ Pantoprazole 40 mg (twice daily)] for 14 days. Results: H. pylori eradication rate was statistically significant higher in patients who received quadruple therapy compared to those who received Clarithromycin-based triple therapy ( 85.7% vs. 67.1 % & P = 0.001 respectively).While, statistically insignificant regarding the treatment side effects in both groups ( 11.4 % vs. 14.3 %, P= 0.33 respectively). Conclusion: Quadruple therapy is preferable to Clarithromycin-contained triple therapy in tolerability and eradication of H. pylori in Egypt. Key words: Helicobacter pylori, Stool antigen test, Clarithromycin-based triple therapy, Quadruple therapy.
   
     
 
       

Author Related Publications

  • Samir Abdelaziem Morsy Afify, "العلاقة بين مستوي مصل البنتراكسين-3 ومرض الكبد الدهني غير الكحولي في المصريين . Relationship Between Serum Pentraxin-3 Level and Non-Alcoholic Fatty Liver Disease in Egyptians .", El Minia University, Faculty of Medicine, 2018 More
  • Samir Abdelaziem Morsy Afify, "تأثير فقدان الوزن علي مستوي هرمون الجريلين في البلازما ، المظاهر السريرية والتمثيل الغذائي عند النساء البدينات المصابات وغير المصابات بمتلازمة المبيض متعدد الكيسات Impact of weight loss on plasma ghrelin level, clinical, and metabolic features of obese women with or without polycystic ovary syndrome .", Middle East Fertility Society Journal 2019, 2019 More
  • Samir Abdelaziem Morsy Afify, "ارتباط مستويات مصل الفسفاتين والتعبير الجيني mRNA بالوظيفة المعرفية وارتفاع ضغط الدم داخل الجمجمة مجهول السبب في النساء المصريات البدينات. Association of serum visfatin and its mRNA expression levels with cognitive function and idiopathic intracranial hypertension in obese Egyptian women .", The Egyptian Journal of Internal Medicine, 2020 More
  • Samir Abdelaziem Morsy Afify, "ارتباط مستوي مصل الأدروبين مع خطر وشدة الاعتلال العصبي الطرفي في مرضي السكري من النوع الثاني. Association of serum adropin with risk and severity of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.", The Egyptian Journal of Internal Medicine, 2020 More
  • Samir Abdelaziem Morsy Afify, "انترلوكين 1- ألفا وتحويل عامل النمو - بيتا 1 كعلامات للتليف الكبدي غير الغازي لإصابة الكبد المزمن بين مرضى أمراض الكبد المزمنة في محافظة الشرقية ، مصر. IL-1α and TGF-β1 as non-Invasive Liver Fibrosis Markers of Chronic Liver Injury among Chronic Liver Diseases Patients in Sharkia Governorate, Egypt .", Afro-Egypt J Infect Endem Dis 2020; 10(2):108-113, 2020 More

Department Related Publications

  • Ayman Abdalrahman Mohamed Nasrllah, "Thyroid Dysfunction and Inflammatory Biomarkers in COPD:Relation to Severity and Exacerbation", Cairo,Egypt, 2013 More
  • Emad Fawzy Hamed Mahmoud, "TYPES AND PREDICTORS OF INTERFERON/RIBAVIRIN INDUCED CARDIAC COMPLICATIONS IN THE EGYPTIAN PATIENTS WITH", مجلة كلية الطب البشرى, 2014 More
  • Munkez Mutee Yusuf Muhamed, "دراسة التغيرات فى حركية المرى لدى مرضى التهاب المفاص الرثياخى", لايوجد, 1900 More
  • Amira Ahmed Mahmoud Monier, "The utility of technetium-99m pertechnetate thyroid scintigraphy assessing thyroid/salivary ratio as an alternative to thyroid uptake percentage in evaluation of thyroid function, with establishing normal reference values of both parameters: single Egyptian center study", Wolters Kluwer Health, 2022 More
  • Ahmed Shehata Mostafa Embaby, "Spontaneous apoptosis and BCL2 gene expression as predictors of early death and short overall survival in acute leukemia patients a prospective case cohort study", Ain Shams University, 2021 More
Tweet